Search & Analyze

Thyrocare Technologies Ltd.

455.30−38.45 (−7.79%)

BSE · 30 Oct, 2:39 PM

: ₹7,858.79 Cr
: 44.58
: 2,19,580
: ₹501.85 - ₹445.40
: ₹662.00 - ₹342.55

Thyrocare Technologies Ltd. (THYROCARE) share price is trading at ₹455.30 on the BSE as of October 30, 2026 at 2:39 PM, down by 7.79% from its of ₹493.75. In today's trading session THYROCARE reached a of 501.85 and of 445.40. The for today is 466.82. The stands at 544.70 and is at 486.16. Looking at , the stock is in Downtrend.

Stock Overview

₹496.30

₹493.75

₹466.82

₹544.70

Price 16.41% below

₹486.16

Price 6.35% below

Key Fundamentals

: 7,858.79 Cr₹7.86 Thousand Crore
: 11.08
: 44.58
: 12.49
: 39.54
: 298.03 Cr₹298.03 Crore
: 2.84 %
Sector
Industry: Hospital & Healthcare Services
: 29.05
: 0.00

Industry Comparison

Ratio	Company	Sector
	44.58	44.58
	0.00	0.20
	12.49	4.68
	3.39	1.81
	2.84 %	0.11 %
Operating Margin	29.66 %	19.15 %

Sector figures are the median of 154 listed Healthcare companies.

Peer Comparison

Name
APOLLO HOSP. APOLLOHOSP	8,344.00	56.01	1,19,973.92	0.25	610.40	38.41%	7,043.50	20.56%	21.73
MANIPALHOS MANIPALHOS	668.00	94.74	87,867.20	0.00	243.43	-4.18%	3,090.63	38.12%	13.93
MAXHEALTH MAXHEALTH	872.25	56.78	84,896.99	0.24	322.96	4.87%	2,366.17	16.70%	14.97
ASTERDM ASTERDM	685.75	183.17	59,774.94	0.45	29.28	-68.70%	1,310.68	21.60%	16.22
FORTIS FORTIS	758.15	54.61	57,237.15	0.13	272.80	2.26%	2,545.03	17.46%	14.07
NH NH	1,720.10	43.15	35,152.10	0.26	207.27	5.37%	2,683.63	78.05%	16.20
MEDANTA MEDANTA	1,269.40	62.08	34,131.31	0.04	157.25	-1.09%	1,304.05	26.50%	19.38
Thyrocare Technologies Ltd. THYROCARE	455.30	44.58	7,858.79	2.84	15.22	-68.17%	270.81	25.07%	38.30

Quarterly Results

consolidated figures in ₹ Crores · Quarterly

Particulars	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
	156.91	177.36	165.92	187.16	193.03	216.53	195.53	223.95	240.02	270.81
Expenses	114.27	129.07	124.19	129.46	135.26	145.18	137.70	148.86	162.75	181.52
	42.64	48.29	41.73	57.70	57.77	71.35	57.83	75.09	77.27	89.29
	27.17%	27.23%	25.15%	30.83%	29.93%	32.95%	29.58%	33.53%	32.19%	32.97%
	3.62	2.61	4.01	4.59	4.65	3.05	-1.18	4.31	4.15	48.61
Interest	0.99	0.76	0.60	0.70	0.78	0.59	-0.09	1.52	1.35	1.57
	11.36	13.07	17.06	13.77	11.41	11.51	21.63	14.03	12.49	13.52
	33.55	36.78	27.92	47.19	50.48	62.58	35.39	64.43	68.29	33.65
	28.64%	28.17%	32.13%	54.29%	24.15%	23.60%	20.74%	24.41%	24.84%	54.77%
	24.17	26.67	19.11	21.70	38.93	47.99	29.01	47.11	52.19	15.89
	4.56	5.04	3.61	4.10	7.35	9.06	1.82	2.96	3.28	1.00

Profit & Loss

consolidated figures in ₹ Crores · Annual

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	12.00	12.00
INCOME:
Operating Income	588.86	526.67	571.88	687.35	829.04
Operating Income (Net)	588.86	526.67	571.88	687.35	829.04
EXPENDITURE :
Increase/Decrease in Stock	-0.88	0.20	-0.28	0.81	-0.24
Cost of Medicines and Consumables	170.57	163.03	166.98	190.27	219.80
Power & Fuel Cost	8.40	10.70	10.15	11.52	11.26
Employee Cost	61.13	106.15	107.86	126.77	138.06
Hospital Operation Expenses	14.72	19.44	61.81	79.02	97.18
Selling, Administration and Other Expenses	83.69	91.90	73.23	82.68	98.81
Miscellaneous Expenses	15.50	12.72	13.37	5.72	18.24
	353.13	404.14	433.12	496.79	583.11
Operating Profit (Excl OI)	235.73	122.53	138.76	190.56	245.93
	29.25	8.42	9.37	15.32	34.27
	264.98	130.95	148.13	205.88	280.20
Interest	3.21	4.83	5.53	3.74	3.96
PBDT	261.77	126.12	142.60	202.14	276.24
	33.87	38.71	47.01	55.26	58.58
Profit Before Taxation & Exceptional Items	227.90	87.41	95.59	146.88	217.66
Exceptional Income / Expenses					-6.17
	227.72	88.59	95.98	145.44	212.88
Provision for Tax	51.58	24.23	26.49	54.69	50.03
	176.14	64.36	69.49	90.75	162.85
Extra items				0.00	0.00
Minority Interest		0.13	1.27	0.76	0.19
Other Consolidated Items	-0.08	1.53	0.29	-0.77	0.38
Consolidated Net Profit	176.06	66.02	71.05	90.74	163.42
Profit Balance B/F	259.92	356.88	343.41	319.19	314.63
Appropriations	435.98	422.90	414.46	409.93	478.05
Equity Dividend %	150.00%	180.00%	180.00%	210.00%	140.00%
	33.28	12.47	13.42	17.12	10.27
Adjusted EPS	11.09	4.16	4.47	5.71	10.27

Balance Sheet

consolidated figures in ₹ Crores

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
	52.90	52.93	52.95	52.99	159.17
Share Warrants & Outstandings	3.44	4.53	4.32	4.33	6.73
Total Reserves	470.23	476.84	469.49	489.43	419.60
Reserve excluding Revaluation Reserve	470.23	476.84	469.49	489.43	419.60
Revaluation reserve				0.00
	526.57	534.30	526.76	546.75	585.50
Minority Interest		0.92	0.86	0.30	0.52
Secured Loans			10.91
Deferred Tax Assets / Liabilities	-5.89	-11.29	-14.82	-8.53	-15.66
Other Long Term Liabilities	15.70	16.12	11.80	16.92	39.18
Long Term Provisions	96.17	143.86	3.06	54.76	69.40
Total Non-Current Liabilities	105.98	148.69	10.95	63.15	92.92
Trade Payables	16.53	23.99	40.11	76.21	65.37
Other Current Liabilities	39.86	39.02	44.45	42.25	40.70
Short Term Borrowings			1.83
Short Term Provisions	158.87	14.08	4.10	3.38	3.84
Total Current Liabilities	215.26	77.09	90.49	121.84	109.91
Total Liabilities	847.81	761.00	629.06	732.04	788.85
Gross Block	422.59	461.10	501.12	542.69	600.65
Less: Accumulated Depreciation	137.64	167.21	195.24	245.48	283.34
Net Block	284.95	293.89	305.88	297.21	317.31
Capital Work in Progress	2.95	1.61	2.55	14.15	3.07
Non Current Investments	20.92	22.10	25.62	24.17	25.14
Long Term Investment	20.92	22.10	25.62	24.17	25.14
Long Term Loans & Advances	113.48	169.40	15.45	57.16	68.79
Other Non Current Assets	4.75	1.07	1.05	1.63	2.25
Total Non-Current Assets	427.05	488.07	350.55	394.32	416.56
Currents Investments	125.21	122.30	136.75	137.36	151.50
Inventories	24.53	27.67	47.52	46.54	48.46
Sundry Debtors	93.20	85.11	43.47	73.00	73.88
Cash and Bank	13.91	28.47	39.89	54.48	68.16
Other Current Assets	2.44	3.11	3.39	12.90	13.48
Short Term Loans and Advances	161.47	6.27	7.49	13.44	16.81
Total Current Assets	420.76	272.93	278.51	337.72	372.29
Net Current Assets (Including Current Investments)	205.50	195.84	188.02	215.88	262.38
Total Assets	847.81	761.00	629.06	732.04	788.85
Contingent Liabilities	1.61	1.61	0.62	2.26	1.86
Total Debt	0.00	0.00	21.60	0.00	0.00
	98.89	100.09	98.67	102.36	36.36
Adjusted Book Value	32.96	33.36	32.89	34.12	36.36

Cash Flow

consolidated figures in ₹ Crores

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	12.00	12.00
	227.90	87.41	95.59	146.88	212.88
Adjustment	21.49	64.57	70.87	73.28	68.64
Changes In working Capital	-79.22	5.79	30.16	11.13	-8.46
Cash Flow after changes in Working Capital	170.17	157.77	196.62	231.29	273.06
Cash Flow from Operating Activities	113.41	129.31	167.63	179.91	213.24
Cash Flow from Investing Activities	-23.57	-38.99	-91.29	-41.11	-23.01
Cash Flow from Financing Activitie	-89.41	-86.18	-84.81	-130.42	-169.59
Net Cash Inflow / Outflow	0.43	4.14	-8.47	8.38	20.64
Opening Cash & Cash Equivalents	13.20	13.63	17.77	9.30	17.68
Closing Cash & Cash Equivalent	13.63	17.77	9.30	17.68	38.32

Ratios

Valuation

44.58

12.49

26.14

8.97

11.08

39.54

Profitability

29.05

38.30

21.42

29.66

19.64

Leverage & Liquidity

0.00

3.39

54.76

Returns

2.84

1.09

Shareholding Pattern

Numbers in percentages

Particulars	Jun '24	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	Dec '25	Mar '26	Jun '26	Sep '26
	71.11	71.11	71.06	71.06	71.06	71.06	60.93	60.92	60.92	51.02
	17.39	16.73	17.44	17.38	17.77	18.32	25.46	26.36	26.36	35.29
	11.49	12.16	11.50	11.56	11.17	10.63	13.61	12.71	12.72	13.69
	28.89	28.89	28.94	28.94	28.94	28.94	39.07	39.08	39.08	48.98
No. of Shareholders	61,636	59,377	56,666	57,403	54,566	54,142	77,619	73,377	73,064	75,186

Mutual Funds Invested(43)

Based on each fund's latest monthly portfolio · Sep 2026

A total of 34 active funds hold 22.83% in Thyrocare Technologies Ltd., contributing to ₹1.94K Cr of holdings

Fund				As of
HS HSBC Midcap Fund - Growth - Direct PlanMid Cap Fund	302.43	1.80	56,61,886	Sep '26
NI Nippon India Small Cap Fund - Growth - Direct PlanSmall cap Fund	276.04	0.34	51,67,803	Sep '26
AB Aditya Birla Sun Life ELSS Tax Saver Fund - Growth - Direct PlanEquity - ELSS - Tax Saver Fund	213.58	1.58	39,98,570	Sep '26
NI Nippon India Pharma Fund - Growth - Direct PlanPharma & Health Care	205.01	2.24	38,37,967	Sep '26
IP ICICI Prudential Dividend Yield Fund - Growth - Direct PlanEquity - Dividend Yield Fund	113.21	1.79	21,19,355	Sep '26
HS HSBC Large & Mid Cap Fund - Growth - Direct PlanLarge & Mid Cap	92.81	1.60	17,37,570	Sep '26
HS HSBC Small Cap Fund - Growth - Direct PlanSmall cap Fund	82.12	0.44	15,37,305	Sep '26
IP ICICI Prudential Healthcare Fund - Growth - Direct PlanPharma & Health Care	80.16	1.17	15,00,766	Sep '26
DS DSP Healthcare Fund - Growth - Direct PlanPharma & Health Care	71.64	1.91	13,41,127	Sep '26
IP ICICI Prudential Innovation Fund - Growth - Direct PlanEquity - Thematic Fund - Other	53.37	0.71	9,99,157	Sep '26

Corporate Actions

Showing: All

Date	Type	Details
2026-10-22	Board Meeting	Quarterly Results
2026-07-16	Board Meeting	Quarterly Results
2026-06-05	AGM

Insider Trading

Date	Person	Category	Transaction Type	Shares
2026-08-13	Docon Technologies Pvt Ltd	13-Aug-26	Block Deal	13,168,657
2026-08-13	Docon Technologies Pvt Ltd	13-Aug-26	Market	2,601,039
2026-08-07	Mohammad Shadab Alam	Market	Sell	100
2026-07-01	Piyush Singh	Market	Buy	250
2026-06-18	Nikhil Bodhankar	Market	Sell	90
2026-06-18	AADITYA BHANDARI	Market	Sell	1,000
2026-06-18	Nikhil Bodhankar	Market	Sell	200
2026-06-15	Nikhil Bodhankar	Market	Sell	90
2026-06-15	Nikhil Bodhankar	Market	Sell	200
2026-06-12	Sarovar Chandra	Market	Buy	450

Sector Overview

HealthcareHospital & Healthcare Services

Thyrocare Technologies Ltd. operates in the Healthcare sector under the Hospital & Healthcare Services industry. This sector is one of the key drivers of the Indian economy and is closely tracked by the relevant Nifty sectoral index.

Company Profile

Corporate information and contact details

Key Management

10 members across the board and senior leadership

Brijesh Kumar

Company Secretary & Compliance Officer

—

Rahul Guha

Chairman & Managing Director, Chief Executive Officer

₹6.11 Cr

Mar '26

Alok Kumar Jagnani

Non Independent & Non Executive Director

—

Indumati Gopinathan